Literature DB >> 19142020

ACTN4 gene mutations and single nucleotide polymorphisms in idiopathic focal segmental glomerulosclerosis.

Shengchuan Dai1, Zhaohui Wang, Xiaoxia Pan, Xiaonong Chen, Weiming Wang, Hong Ren, Qi Feng, John Cijiang He, Bin Han, Nan Chen.   

Abstract

AIM: To investigate the association between mutations or single nucleotide polymorphisms (SNPs) of the gene ACTN4 in Chinese patients with idiopathic focal segmental glomerulosclerosis (FSGS).
MATERIALS AND METHODS: Genomic DNA of 82 Chinese idiopathic FSGS patients and 70 healthy people were used to analyze ACTN4 gene mutations by polymerase chain reaction, direct sequencing and GenBank matching. Hair follicle DNA of novel mutated patients' parents were sequenced and alpha-actinin-4 expression in patients' kidney was examined by immunofluorescence. For SNPs, after the Hardy-Weinberg equilibrium test, allele association and the frequencies of genotypes were analyzed, followed by association analysis between genotypes and clinical diagnosis.
RESULTS: We found a heterozygous candidate mutation 184T>A (S62T) in 1 patient and a 5' UTR candidate mutation 1-34C>T in another patient. Both patients had non-nephrotic syndrome FSGS with reduced kidney alpha-actinin-4 expression. Promoter activity analysis suggests that the 1-34C>T candidate mutation may affect the transcriptional regulation of ACTN4 gene. Additionally, 6 novel silent variants and 2 novel SNPs were also found in this study. Novel SNP 484 + 87C>G had a significant association with the level of urine protein excretion in these idiopathic FSGS patients.
CONCLUSIONS: Our data suggest that mutations and SNP of ACTN4 gene may contribute to be associated with Chinese idiopathic FSGS. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19142020     DOI: 10.1159/000191198

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  9 in total

Review 1.  Genetic basis of adult-onset nephrotic syndrome and focal segmental glomerulosclerosis.

Authors:  Jian Liu; Weiming Wang
Journal:  Front Med       Date:  2017-08-03       Impact factor: 4.592

2.  α Actinin 4 (ACTN4) Regulates Glucocorticoid Receptor-mediated Transactivation and Transrepression in Podocytes.

Authors:  Xuan Zhao; Simran Khurana; Sharmistha Charkraborty; Yuqian Tian; John R Sedor; Leslie A Bruggman; Hung-Ying Kao
Journal:  J Biol Chem       Date:  2016-12-20       Impact factor: 5.157

3.  Proteomic analysis of differentially expressed proteins between stenotic and normal colon segment tissues derived from patients with Hirschsprung's disease.

Authors:  Hong Gao; Xiaojing He; Mei Wu; Zhibo Zhang; Dajia Wang; Liangying Lv; Zhenwei Su; Ying Huang
Journal:  Protein J       Date:  2011-02       Impact factor: 2.371

4.  α-Actinin 4 potentiates nuclear factor κ-light-chain-enhancer of activated B-cell (NF-κB) activity in podocytes independent of its cytoplasmic actin binding function.

Authors:  Xuan Zhao; Kuo-Sheng Hsu; Jun Hee Lim; Leslie A Bruggeman; Hung-Ying Kao
Journal:  J Biol Chem       Date:  2014-11-19       Impact factor: 5.157

5.  Analysis of recessive CD2AP and ACTN4 mutations in steroid-resistant nephrotic syndrome.

Authors:  Geneviève Benoit; Eduardo Machuca; Fabien Nevo; Olivier Gribouval; David Lepage; Corinne Antignac
Journal:  Pediatr Nephrol       Date:  2009-12-03       Impact factor: 3.714

6.  Progress in pathogenesis of proteinuria.

Authors:  Aihua Zhang; Songming Huang
Journal:  Int J Nephrol       Date:  2012-05-24

7.  Rapid progression to end-stage renal disease in a child with a sporadic ACTN4 mutation.

Authors:  Aadil K Kakajiwala; Kevin E Meyers; Tricia Bhatti; Bernard S Kaplan
Journal:  Clin Nephrol Case Stud       Date:  2015-09-23

8.  The Role of Glucocorticoid Receptors in Podocytes and Nephrotic Syndrome.

Authors:  Xuan Zhao; Daw-Yang Hwang; Hung-Ying Kao
Journal:  Nucl Receptor Res       Date:  2018-04-24

9.  Case report and literature review: A de novo pathogenic missense variant in ACTN4 gene caused rapid progression to end-stage renal disease.

Authors:  Zhechi He; Ke Wu; Wenqing Xie; Jianghua Chen
Journal:  Front Pediatr       Date:  2022-08-25       Impact factor: 3.569

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.